Biologic Profiles of Invasive Breast Cancers Detected Only With Digital Breast Tomosynthesis

2017 ◽  
Vol 209 (6) ◽  
pp. 1411-1418 ◽  
Author(s):  
Jin You Kim ◽  
Hyun Jung Kang ◽  
Jong Ki Shin ◽  
Nam Kyung Lee ◽  
You Seon Song ◽  
...  
2021 ◽  
Author(s):  
Léa Manse ◽  
Martine Boisserie-Lacroix ◽  
Véronique Brouste ◽  
Marie-Pierre Depetiteville ◽  
Benoît Mesurolle ◽  
...  

Abstract Objective To describe BI-RADS features and evaluate conspicuity of breast cancer on digital breast tomosynthesis (DBT) according to their molecular profile. Materials and method Institutional review board was obtained for this retrospective study. Consecutive patients with histologically proven breast cancers who underwent digital breast tomosynthesis (DBT) with 2D synthetic mammography (SM) and digital mammography (DM) at the time of diagnosis were included. Morphological features and conspicuity of cancers on DM, SM and DBT were evaluated in consensus by two breast radiologists. Imaging features were compared across molecular subtypes (luminal, triple negative (TN) and HER2+) using Fisher’s exact test and between DBT and SM and DM using McNemar’s test. Conspicuity was compared between DBT and SM and DM using Wilcoxon matched pairs test and between each molecular subtype using the Wilcoxon test. Results One hundred and eleven consecutive patients were included. On DBT, TN cancers more frequently presented as masses with microlobulated margins (P = 0.04) while HER2 + cancers were more often associated with microcalcifications (P = 0.02). Greater conspicuity on DBT in comparison to DM was observed for cancers with low Ki67 (P = .015), less aggressive tumours (P = .005), positive ER (P = 0.005), positive PR (P = .005) or negative HER2 (P = .024), and for luminal molecular profiles (P = 0.012) while no difference was observed between the two techniques for TN (P = .73) and HER+ (P = .79) tumours. Conclusion DBT reveals specific features of breast cancers according to their molecular characteristics. In comparison with DM, DBT improves conspicuity of luminal subtype cancers and tumours demonstrating less aggressive features on pathology.


The Breast ◽  
2015 ◽  
Vol 24 (5) ◽  
pp. 649-655 ◽  
Author(s):  
Kyung Jin Nam ◽  
Boo-Kyung Han ◽  
Eun Sook Ko ◽  
Ji Soo Choi ◽  
Eun Young Ko ◽  
...  

Breast Cancer ◽  
2015 ◽  
Vol 23 (6) ◽  
pp. 886-892 ◽  
Author(s):  
Woo Jung Choi ◽  
Hak Hee Kim ◽  
Sun Young Lee ◽  
Eun Young Chae ◽  
Hee Jung Shin ◽  
...  

2021 ◽  
Vol 7 (9) ◽  
pp. 185
Author(s):  
Giovanna Romanucci ◽  
Lisa Zantedeschi ◽  
Anna Ventriglia ◽  
Sara Mercogliano ◽  
Maria Vittoria Bisighin ◽  
...  

Objectives: To compare the conspicuity of lobular breast cancers at digital breast tomosynthesis (DBT) versus synthesized 2D mammography (synt2D). Materials and methods: Seventy-six women (mean age 61.2 years, range 50–74 years) submitted to biopsy in our institution, from 2019 to 2021, with proven invasive lobular breast cancer (ILC) were enrolled in this retrospective study. The participants underwent DBT and synt2D. Five breast radiologists, with different years of experience in breast imaging, independently assigned a conspicuity score (ordinal 6-point scale) to DBT and synt2D. Lesion conspicuity was compared, for each reader, between the synt2D overall conspicuity interpretation and DBT overall conspicuity interpretation using a Wilcoxon matched pairs test. Results: A total of 50/78 (64%) cancers were detected on both synt2D and DBT by all the readers, while 28/78 (26%) cancers where not recognized by at least one reader on synt2D. For each reader, in comparison with synt2D, DBT increased significantly the conspicuity of ILC (p < 0.0001). The raw proportion of high versus low conspicuity by modality confirmed that cancers were more likely to have high conspicuity at DBT than synt2D. Conclusions: ILCs were more likely to have high conspicuity at DBT than at synt2D, increasing the chances of the detection of ILC breast cancer.


2019 ◽  
Vol 85 (8) ◽  
pp. 855-857
Author(s):  
Anthony M. Scott ◽  
Madison G. Lashley ◽  
Nicholas B. Drury ◽  
Paul S. Dale

The effect of mammographic screening on the natural history and evolution of breast cancer treatment cannot be overstated; however, despite intensive and resource consuming screening, advanced breast cancer is still diagnosed frequently. The development of three-dimensional mammography or digital breast tomosynthesis (DBT) has already demonstrated greater sensitivity in the diagnosis of breast pathology and effectiveness in identifying early breast cancers. In addition to being a more sensitive screening tool, other studies indicate DBT has a lower call-back rate when compared with traditional DM. This study compares call-back rates between these two screening tools. A single institution, retrospective review was conducted of almost 20,000 patient records who underwent digital mammography or DBTin the years 2016 to 2018. These charts were analyzed for documentation of imaging type, Breast Imaging Reporting and Data System 0 status, call-back status, and type of further imaging that was required. Charts for 19,863 patients were reviewed, 17,899 digital mammography examinations were conducted compared with 11,331 DBT examinations resulting in 1,066 and 689 Breast Imaging Reporting and Data System 0 studies, respectively. Of the DM call-backs, 82.08 per cent were recommended for additional radiographic imaging and 17.82 per cent for ultrasound imaging. In the DBT group, only 39.77 per cent of callbacks were recommended for additional radiographic imaging and 60.09 per cent for ultrasound imaging. Our data suggest that DBT results in less call-back for additional mammographic images as compared with digital mammography. DBT may offer benefits over DM, including less imaging before biopsy, less time before biopsy, quicker diagnosis, and improved patient satisfaction.


Sign in / Sign up

Export Citation Format

Share Document